Search
for
Sort by
Research 30 of 1000+
- Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Risk of Polycystic Ovary Syndrome in Women Exposed to Fine Air Pollutants and Acidic Gases: A Nationwide Cohort Analysis
- Risk factors for diabetic foot ulcers mortality and novel negative pressure combined with platelet-rich plasma therapy in the treatment of diabetic foot ulcers
- Risk of valproic acid-related alopecia: A systematic review and meta-analysis
- Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey
- Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan
- Risks of Skin, Hair, and Nail Supplements
- Risk of Depression Associated With Finasteride Treatment
- Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?
- RISK FACTORS, PREVALENCE AND DIAGNOSIS OF HUTCHISON GILFORD SYNDROME WITH SPECIAL REFERENCE TO CASE REPORTS
- Risks related to the use of finasteride (propecia) in pregnant women.
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Risks Associated with 5α-Reductase Inhibitor Use: Analysis of Adverse Drug Reactions Reported to EudraVigilance
- Risks of minoxidil toxicity for household pets
- Risks of Protein Conditioner Application under the Impact of Heat and/or Gamma Irradiation in Albino Rats
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Risk Factors and Epidemiology of Acne Severity and Acne Scar Development: A Comprehensive Clinical Study
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Risk associated with the use of 5-alpha reductase inhibitors with minoxidil in treatment of male androgenetic alopecia – literature review
- Risk of Poor Glycemic Control in Tamsulosin Versus Finasteride Users with Type 2 Diabetes Mellitus
- Risk factors and early preventive measures for long COVID in non-hospitalized patients: analysis of a large cohort in the United Arab Emirates
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Using risk analysis to guide changes to compounding formulae
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- Risk factors for prostate cancer: a case-control study in Greece
- Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study